BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

807 related articles for article (PubMed ID: 12621133)

  • 1. A randomized trial of aspirin to prevent colorectal adenomas.
    Baron JA; Cole BF; Sandler RS; Haile RW; Ahnen D; Bresalier R; McKeown-Eyssen G; Summers RW; Rothstein R; Burke CA; Snover DC; Church TR; Allen JI; Beach M; Beck GJ; Bond JH; Byers T; Greenberg ER; Mandel JS; Marcon N; Mott LA; Pearson L; Saibil F; van Stolk RU
    N Engl J Med; 2003 Mar; 348(10):891-9. PubMed ID: 12621133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
    Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R
    N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celecoxib for the prevention of colorectal adenomatous polyps.
    Arber N; Eagle CJ; Spicak J; Rácz I; Dite P; Hajer J; Zavoral M; Lechuga MJ; Gerletti P; Tang J; Rosenstein RB; Macdonald K; Bhadra P; Fowler R; Wittes J; Zauber AG; Solomon SD; Levin B;
    N Engl J Med; 2006 Aug; 355(9):885-95. PubMed ID: 16943401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group.
    Baron JA; Beach M; Mandel JS; van Stolk RU; Haile RW; Sandler RS; Rothstein R; Summers RW; Snover DC; Beck GJ; Bond JH; Greenberg ER
    N Engl J Med; 1999 Jan; 340(2):101-7. PubMed ID: 9887161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.
    Bresalier RS; Sandler RS; Quan H; Bolognese JA; Oxenius B; Horgan K; Lines C; Riddell R; Morton D; Lanas A; Konstam MA; Baron JA;
    N Engl J Med; 2005 Mar; 352(11):1092-102. PubMed ID: 15713943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network.
    Alberts DS; Martínez ME; Roe DJ; Guillén-Rodríguez JM; Marshall JR; van Leeuwen JB; Reid ME; Ritenbaugh C; Vargas PA; Bhattacharyya AB; Earnest DL; Sampliner RE
    N Engl J Med; 2000 Apr; 342(16):1156-62. PubMed ID: 10770980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group.
    Schatzkin A; Lanza E; Corle D; Lance P; Iber F; Caan B; Shike M; Weissfeld J; Burt R; Cooper MR; Kikendall JW; Cahill J
    N Engl J Med; 2000 Apr; 342(16):1149-55. PubMed ID: 10770979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.
    Baron JA; Sandler RS; Bresalier RS; Quan H; Riddell R; Lanas A; Bolognese JA; Oxenius B; Horgan K; Loftus S; Morton DG;
    Gastroenterology; 2006 Dec; 131(6):1674-82. PubMed ID: 17087947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin and folic acid for the prevention of recurrent colorectal adenomas.
    Logan RF; Grainge MJ; Shepherd VC; Armitage NC; Muir KR;
    Gastroenterology; 2008 Jan; 134(1):29-38. PubMed ID: 18022173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup.
    Winawer SJ; Zauber AG; O'Brien MJ; Ho MN; Gottlieb L; Sternberg SS; Waye JD; Bond J; Schapiro M; Stewart ET
    N Engl J Med; 1993 Apr; 328(13):901-6. PubMed ID: 8446136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal adenoma characteristics as predictors of recurrence.
    Bonithon-Kopp C; Piard F; Fenger C; Cabeza E; O'Morain C; Kronborg O; Faivre J;
    Dis Colon Rectum; 2004 Mar; 47(3):323-33. PubMed ID: 14991494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics.
    Schatzkin A; Lanza E; Freedman LS; Tangrea J; Cooper MR; Marshall JR; Murphy PA; Selby JV; Shike M; Schade RR; Burt RW; Kikendall JW; Cahill J
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):375-83. PubMed ID: 9162304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.
    Alberts DS; Martínez ME; Hess LM; Einspahr JG; Green SB; Bhattacharyya AK; Guillen J; Krutzsch M; Batta AK; Salen G; Fales L; Koonce K; Parish D; Clouser M; Roe D; Lance P;
    J Natl Cancer Inst; 2005 Jun; 97(11):846-53. PubMed ID: 15928305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
    Cole BF; Baron JA; Sandler RS; Haile RW; Ahnen DJ; Bresalier RS; McKeown-Eyssen G; Summers RW; Rothstein RI; Burke CA; Snover DC; Church TR; Allen JI; Robertson DJ; Beck GJ; Bond JH; Byers T; Mandel JS; Mott LA; Pearson LH; Barry EL; Rees JR; Marcon N; Saibil F; Ueland PM; Greenberg ER;
    JAMA; 2007 Jun; 297(21):2351-9. PubMed ID: 17551129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group.
    Greenberg ER; Baron JA; Tosteson TD; Freeman DH; Beck GJ; Bond JH; Colacchio TA; Coller JA; Frankl HD; Haile RW
    N Engl J Med; 1994 Jul; 331(3):141-7. PubMed ID: 8008027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380.
    Lieberman DA; Weiss DG; Bond JH; Ahnen DJ; Garewal H; Chejfec G
    N Engl J Med; 2000 Jul; 343(3):162-8. PubMed ID: 10900274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention.
    Benamouzig R; Uzzan B; Martin A; Deyra J; Little J; Girard B; Chaussade S;
    Gut; 2010 May; 59(5):622-9. PubMed ID: 20427397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-definition chromocolonoscopy vs. high-definition white light colonoscopy for average-risk colorectal cancer screening.
    Kahi CJ; Anderson JC; Waxman I; Kessler WR; Imperiale TF; Li X; Rex DK
    Am J Gastroenterol; 2010 Jun; 105(6):1301-7. PubMed ID: 20179689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.